DAX1 gene expression upregulated by steroidogenic factor 1 in an adrenocortical Carcinoma cell line

Biochemical and Molecular Medicine

Volumn 61, Issue 1, 1997, Pages 1-8

  Vilain, Eric ^a   Guo, Weiwen ^a   Zhang, Yao Hua ^a   McCabe, Edward R B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; HORMONE RECEPTOR; STEROIDOGENIC FACTOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADRENAL CORTEX CARCINOMA; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PROMOTER REGION;

EID: 0031171619     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1997.2601     Document Type: Article

References (36)

1. 1. Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, Guo W, Lalli E, Moser C, Walker AP, McCabe ERB, Meitinger T, Monaco AP, Sassone-Corsi P, Camerino G. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372:635-641, 1994.
2. 2. Muscatelli F, Strom TM, Walker AP, Zanaria E, Recan D, Meindl A, Bardoni B, Guioli S, Zehetner G, Rabel W, Schwarz HP, Kaplan JC, Camerino G, Meitinger T, Monaco AP. Mutations in the Dax-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372:672-676, 1994.
3. 3. Guo W, Mason JS, Stone CG Jr, Morgan SA, Madu SI, Baldini A, Lindsay EA, Biesecker LG, Copeland KC, Horlick MN, Pettigrew AL, Zanaria E, McCabe ERB. Diagnosis of X-linked adrenal hypoplasia congenita by mutation analysis of the DAX1 gene. J Am Med Assoc 274:324-330, 1995.
4. 4. Habiby RL, Boepple P, Nachtigall L, Sluss PM, Crowley WF, Jameson JL. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: Evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J Clin Invest 98:1055-1062, 1996.
5. 5. Seltzer WK, Firminger H, Klein J, Pike A, Fennessey P, McCabe ERB. Adrenal dysfunction in glycerol kinase deficiency. Biochem Med 33:189-199, 1985.
6. 6. Marsden HB, Zakhour HD. Cytomegalic adrenal hypoplasia with pituitary cytomegaly. Virchows Arch Abt A Pathol Anat Histol 378:105-110, 1978.
7. 7. Arn P, Chen H, Tuck-Muller CM, Mankinen C, Wachtel G, Li S, Shen C-C, Wachtel SS. SRVX, a sex reversing locus in Xp21.2 to p22.11. Hum Genet 93:389-393, 1994.
8. 8. Bardoni B, Zanaria E, Guioli S, Floridia G, Worley K, Tonini G, Ferrante E, Chiumello G, McCabe ERB, Fraccaro M, Zuffardi O, Camerino G. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nature Genet 7:497-501, 1994.
9. 9. Seol W, Choi HS, Moore DD. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272:1336-1339, 1996.
10. 10. Guo W, Burris TP, McCabe ERB. Expression of DAX-1, the gene responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism, in the hypothalamic-pituitary-adrenal/gonadal axis. Biochem Mol Med 56:8-13, 1995.
11. 11. Swain A, Zanaria E, Hacker A, Lovell-Badge R, Camerino G. Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nature Genet 12:404-409, 1996.
12. 12. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen WH, Nachtigal MW, Abbud R, Nilson JH, Parker KL. The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 8:2302-2312, 1994.
13. 13. Taketo M, Parker KL, Howard TA, Tsukiyama T, Wong M, Niwa O, Morton CC, Miron PM, Seldin MF. Homologs of Drosophila Fushi-Tarazu factor 1 map to mouse chromosome 2 and human chromosome 9q33. Genomics 25:565-567, 1995.
14. 14. Ikeda Y, Lala DS, Luo X, Kim E, Moisan MP, Parker KL. Characterization of the mouse FTZ-F1 gene, which encodes a key regulator of steroid hydroxylase gene expression. Mol Encocrinol 7:852-860, 1993.
15. 15. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The RXR heterodimers and orphan receptors. Cell 83:835-839, 1995.
16. 16. Lynch JP, Lala DS, Peluso JJ, Luo W, Parker KL, White BA. Steroidogenic factor 1, an orphan nuclear receptor, regulates the expression of the rat aromatase gene in gonadal tissues. Mol Endocrinol 7:776-786, 1993.
17. 17. Shen WH, Moore CC, Ikeda Y, Parker KL, Ingraham HA. Nuclear receptor steroidogenic factor 1 regulates the Mullerian inhibiting substance gene: A link to the sex determination cascade. Cell 7:651-661, 1994.
18. 18. Rice DA, Mouw AR, Bogerd AM, Parker KL. A shared promoter element regulates the expression of three steroidogenic enzymes. Mol Endocrinol 5:1552-1561, 1991.
19. 19. Barnhart KM, Mellon PL. The orphan nuclear receptor, steroidogenic factor-1, regulates the glycoprotein hormone alpha-subunit gene in pituitary gonadotropes. Mol Endocrinol 8:878-885, 1994.
20. 20. Halvorson LM, Kaiser UB, Chin WW. Stimulation of luteinizing hormone beta gene promoter activity by the orphan nuclear receptor, steroidogenic factor-1. J Biol Chem 271:6645-6650, 1996.
21. 21. Keri RA, Nilson JH. A steroidogenic factor-1 binding site is required for activity of the luteinizing hormone beta subunit promoter in gonadotropes of transgenic mice. J Biol Chem 271:10782-10785, 1996.
22. 22. Burris TP, Guo W, Le T, McCabe ERB. Identification of a putative steroidogenic factor-1 response element in the DAX-1 promoter. Biochem Biophys Res Commun 214:576-581, 1995.
23. 23. Parker KL, Schimmer BP. The roles of the nuclear hormone receptor steroidogenic factor 1 in endocrine differentiation and development. Trends Endocrinol Metab 7:203-207, 1996.
24. 24. Ikeda Y, Shen W-H, Ingraham HA, Parker KL. Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol Endocrinol 8:654-662, 1994.
25. 25. Ikeda Y, Swain A, Weber TJ, Hentges KE, Zanaria E, Lalli E, Tamai KT, Sassone-Corsi P, Lovell-Badge R, Camerino G, Parker KL. Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: Potential links in endocrine development. Mol Endocrinol 10:1261-1272, 1996.
26. 26. Luo X, Ikeda Y, Parker KL. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77:481-490, 1994.
27. 27. Frohman MA. In PCR Protocols: A Guide to Methods and Applications (Innis MA, Gelfand DH, Sninsky JJ, White TJ, Eds.). San Diego: Academic Press, 1990, pp 28-38.
28. 28. Staels B, Hum DW, Miller WL. Regulation of steroidogenesis in NCI-H295 cells: A cellular model of the human fetal adrenal. Mol Endocrinol 7:423-433, 1993.
29. 29. De Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S. Firefly luciferase gene: Structure and expression in mammalian cells. Mol Cell Biol 7:725-737, 1987.
30. 30. Bae DS, Schaefer ML, Partan BW, Muglia L. Characterization of the mouse DAX1 gene reveals evolutionary conservation of a unique amino-terminal motif and widespread expression in mouse tissue. Endocrinology 137:3921-3927, 1996.
31. 31. Heckert LL, Schultz K, Nilson JH. Different composite regulatory elements direct expression of the human alpha subunit gene to pituitary and placenta. J Biol Chem 270:26497-26504, 1995.
32. 32. Yu RN, Ito M, Jameson JL. Transcriptional regulation of the mouse DAX1 promoter by steroidogenic factor 1. In Program of the 10th International Congress of Endocrinology, San Francisco, 1996, P3-173. [Abstract]
33. 33. Wilson TE, Fahrner TJ, Milbrandt J. The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol Cell Biol 13:5794-5804, 1993.
34. 34. Forman BM, Umesono K, Chen J, Evans RM. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541-550, 1995.
35. 35. Majdic G, Sanders PTK. Differential patterns of expression of DAX-1 and steroidogenic factor-1 (SF-1) in the fetal rat testis. Endocrinology 137:3586-3589, 1996.
36. 36. McCabe ERB. Sex and the single DAX1: Too little is bad, but can we have too much? J Clin Invest 98:881-882, 1996.